KK Shah Hospitals FY26 Results: Net loss widens to ₹62.27L
KK Shah Hospitals reported a widened net loss of ₹62.27 lakh for FY26, despite a 4.8% revenue increase to ₹942.76 lakh. Higher expenses and a drop in other income drove the loss, while the company expanded infrastructure with a new hospital and advanced diagnostics.

*this image is generated using AI for illustrative purposes only.
kk shah hospitals reported a net loss of ₹62.27 lakh for the financial year ended March 31, 2026 (FY26), widening significantly from a net loss of ₹32.72 lakh in FY25. The company’s 4th Annual General Meeting (AGM) is scheduled for August 18, 2026, at its registered office in Ratlam, Madhya Pradesh, where shareholders will approve the audited financial statements and seek consent for director remuneration exceeding statutory limits under Section 197 of the Companies Act, 2013.
Despite the increased loss, revenue from operations grew 4.8% year-on-year to ₹942.76 lakh, up from ₹899.86 lakh in FY25. Total income stood at ₹961.71 lakh, supported by other income of ₹18.94 lakh. However, total expenses rose to ₹1,034.55 lakh from ₹988.04 lakh in the prior year, leading to a profit before tax deficit of ₹72.84 lakh. After accounting for a deferred tax charge of ₹10.57 lakh, the final net loss reached ₹62.27 lakh.
Financial Performance Snapshot
| Metric | FY26 (₹ Lakh) | FY25 (₹ Lakh) | Change |
|---|---|---|---|
| Revenue from Operations | 942.76 | 899.86 | +4.8% |
| Other Income | 18.94 | 55.54 | -65.9% |
| Total Expenses | 1,034.55 | 988.04 | +4.7% |
| Profit Before Tax | -72.84 | -32.64 | Wider Loss |
| Net Profit After Tax | -62.27 | -32.72 | Wider Loss |
The Board decided against declaring any dividend for FY26 due to the incurred losses. Reserves and surplus declined to ₹598.47 lakh from ₹660.74 lakh in the previous year. The company’s authorized capital remains at ₹7.50 crore, with paid-up capital of ₹6.81 crore.
Operational Developments
Management highlighted strategic infrastructure expansions as key drivers for future growth. During FY26, the company commissioned a new 65-bed hospital facility in Thandla, aiming to improve regional healthcare accessibility. Diagnostic capabilities were enhanced through the installation of an advanced CT Scan machine and the commencement of installation for a Siemens Magnetom Essenza 1.5T MRI Scanner. Additionally, the company introduced robotic technology for surgical procedures and expanded its Outpatient Departments (OPDs) to manage increasing patient inflow.
What the Numbers Show
A critical divergence exists between operating revenue growth and profitability metrics. While revenue from operations increased by nearly 5%, other income collapsed by 66%, falling from ₹55.54 lakh to ₹18.94 lakh. This sharp decline in non-operating income, combined with a 4.7% rise in total expenses, underscores that the widening loss is driven by both reduced ancillary earnings and rising operational costs. Employee benefit expenses rose to ₹268.95 lakh from ₹254.23 lakh, while depreciation charges more than doubled to ₹168.37 lakh from ₹101.27 lakh, reflecting significant capital investments in new assets that have yet to translate into proportional revenue gains.
Governance and Compliance
The AGM agenda includes the re-appointment of Dr. Milli Shah as Executive Director, who retires by rotation. Shareholders will also vote on a special resolution to approve remuneration for directors exceeding the overall managerial limit of 11% of net profits, as permitted under Section 197 read with Schedule V of the Companies Act, 2013. M/s A Y & Company served as statutory auditors, issuing an unqualified report, while M/s Dilip Swarnkar & Associates conducted the secretarial audit with no adverse remarks.
Historical Stock Returns for KK Shah Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +0.93% | -2.94% | +2.61% | -0.15% | -33.80% |
How long will it take for the new Thandla hospital and advanced diagnostic equipment to reach full occupancy and offset the doubled depreciation charges?
What specific cost-control measures is management implementing to address the rising employee benefit expenses despite only modest revenue growth?
Given the sharp decline in other income, what strategies are being employed to diversify non-operating revenue streams in FY27?

































